How should I adjust my premixed 70/30 insulin (70% NPH, 30% regular) when my capillary blood glucose measured at 4 pm is elevated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adjusting 70/30 Insulin for Elevated 4 PM Blood Glucose

Increase your morning dose of 70/30 insulin by 1-2 units (or 10-15% of the current dose) to address the elevated 4 PM glucose reading. 1

Understanding the Pharmacokinetics

The 4 PM glucose reading reflects the action of your morning 70/30 insulin dose, specifically the NPH component. In a twice-daily 70/30 regimen:

  • The morning dose controls glucose through lunch and into the afternoon
  • The evening dose controls overnight and fasting glucose

Since 70/30 insulin contains 70% NPH (intermediate-acting) and 30% regular insulin, the NPH component from your morning injection peaks approximately 4-8 hours after administration, directly influencing your 4 PM reading.

Specific Titration Algorithm

Follow this structured approach 1:

  1. Increase the morning 70/30 dose by:

    • 1-2 units per adjustment, OR
    • 10-15% of the current morning dose
  2. Timing of adjustments:

    • Make changes every 3 days to assess effect
    • Do not adjust more frequently unless glucose is dangerously elevated
  3. Monitor for hypoglycemia:

    • If hypoglycemia occurs without clear cause (missed meal, unusual activity), reduce the dose by 10-20% 1
    • Check glucose before lunch and mid-afternoon to ensure you're not dropping too low before the 4 PM reading

Standard Dosing Distribution

When using twice-daily 70/30 insulin, the typical distribution is 1:

  • 2/3 of total daily dose before breakfast
  • 1/3 of total daily dose before dinner

This means your morning dose should be approximately double your evening dose, which is why it has the dominant effect on afternoon glucose levels.

Critical Pitfalls to Avoid

Do not adjust the evening dose to fix a 4 PM glucose problem—this is a common error. The evening dose controls overnight and fasting glucose, not afternoon readings.

Watch for the "lunch effect": If you're eating a large lunch or high-carbohydrate lunch, the elevated 4 PM glucose may reflect inadequate prandial (regular insulin) coverage from the morning dose. The 30% regular component may be insufficient for your meal pattern.

Assess for overbasalization: If you continue increasing the morning dose but the 4 PM glucose remains elevated while fasting glucose is well-controlled, this suggests you may need to transition to a more flexible regimen 1. Signs include:

  • Large differences between bedtime and morning glucose
  • Large differences between pre-meal and post-meal glucose
  • Recurrent hypoglycemia at other times of day

When to Consider Regimen Change

If you require more than 0.5-1.0 units/kg/day total insulin and still have elevated 4 PM readings despite appropriate titration, consider switching to a basal-bolus regimen rather than continuing to escalate the 70/30 doses 1, 2. This allows independent adjustment of:

  • Basal insulin for background glucose control
  • Separate prandial doses for each meal

The 2025 ADA guidelines explicitly recommend considering self-mixed or split insulin plans when premixed formulations don't achieve glycemic targets 1.

Monitoring Requirements

  • Check glucose at 4 PM consistently for 3 days after each adjustment
  • Also monitor pre-lunch glucose to ensure you're not experiencing mid-day hypoglycemia
  • If using continuous glucose monitoring, review the entire afternoon glucose curve, not just the 4 PM point value

Target glucose range: Aim for 80-130 mg/dL (4.4-7.2 mmol/L) at 4 PM, though this should be individualized based on your overall diabetes management goals and hypoglycemia risk 2.

Related Questions

What is the recommended starting dose of Humulin 70/30 (human insulin 70% NPH, 30% regular) for an adult patient?
What is the appropriate starting dose of insulin Mixtard 70/30 (premixed human insulin containing 70% NPH and 30% regular insulin) for a 74‑kg male, and what definitive test should be used to determine whether his diabetes is type 1 or type 2?
For a 45-year-old Hispanic male weighing 98.4 kg with newly diagnosed type 2 diabetes and normal renal function, currently on 30 U insulin glargine (Lantus) and an insulin-to-carbohydrate ratio of 1 U per 5 g carbohydrate, with post‑meal insulin drip rates of 6, 4, 8, 6 U and overnight fasting drip rates of 2 U each hour, what should the insulin-to-carbohydrate ratio, basal insulin glargine dose, and insulin sensitivity factor be?
A patient taking 30 units of insulin glargine (Lantus) at bedtime has fasting glucose around 215 mg/dL; how much should the insulin dose be increased?
For a 21‑year‑old female weighing 79.3 kg with type 2 diabetes who takes methylprednisolone 1000 mg at 11 am together with NPH insulin (neutral protamine Hagedorn) 70 U (insulin‑to‑carbohydrate ratio 3 g/unit, insulin sensitivity factor 10 mg/dL per unit) and insulin glargine (Lantus) 20 U at 8 pm, with blood glucose readings of 383 mg/dL at 1 pm after eating 48 g carbohydrate, 344 mg/dL at 4 pm, 286 mg/dL at 6 pm, 272 mg/dL at 8 pm, and 221 mg/dL at 10 pm, what should the NPH insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
What blood pressure changes occur during running, and what systolic and diastolic limits are considered safe for a healthy adult versus a person with hypertension, including medication considerations?
Can tadalafil be taken concomitantly with tacrolimus?
Can an untreated Enterococcus faecalis infection cause widespread body aches and reactive arthritis despite a negative STI test?
What is the prognosis for mandibular ameloblastoma?
What is the typical clinical course of drug‑induced liver disease (drug‑induced liver injury) compared with autoimmune liver disease (autoimmune hepatitis)?
How should rebound edema be managed in a patient who abruptly discontinued diuretics used for weight loss and now presents with marked peripheral edema and approximately 10‑pound weight gain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.